U.S. health regulators significantly widened the nation’s Covid-19 booster campaign, clearing use of extra doses of Moderna Inc. and Johnson & Johnson vaccines and also saying people can get a shot that is different from what they had previously received. The moves, announced by the Food and Drug Administration on Wednesday, will make boosters available to the majority of adults who…

The company’s revenue rose 11% year over year in the third quarter to $23.34 billion. Its results are closely watched in the healthcare sector because its products span multiple categories. Medical-device sales grew 7.6% amid a higher level of surgical procedures. Pharmaceutical sales were up 14%, the result of more prescriptions of drugs for multiple…

Advisers to the Food and Drug Administration voted unanimously Friday to recommend the agency authorize an extra dose of Johnson & Johnson’s Covid-19 vaccine, to shore up protection against the coronavirus. The panel of outside doctors and experts voted 19-0 to recommend that all adults who received a first dose of the J&J vaccine should get the second…

The healthcare company said Thursday that a corporate affiliate holding talc-related liabilities had filed for chapter 11 protection “to resolve all claims related to cosmetic talc in a manner that is equitable to all parties, including any current and future claimants.” The chapter 11 filing makes J&J the latest company to turn to chapter 11…

A booster of Johnson & Johnson’s Covid-19 vaccine showed signs of significantly bolstering the immune defenses of study subjects, federal health regulators said Wednesday. The regulators cautioned, however, that data was limited and they had to rely on J&J’s own analysis for some of the study findings, rather than conducting their own. The Food and Drug…